105
Views
2
CrossRef citations to date
0
Altmetric
Letters to the Editor

Regression of diffuse large B-cell lymphoma in sphenoid and ethmoid sinuses following treatment with loxoprofen

, &
Pages 721-723 | Received 25 Mar 2015, Accepted 30 Jun 2015, Published online: 05 Oct 2015

References

  • Matsuo T, Ichimura K, Yoshino T. Spontaneous regression of bilateral conjunctival extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. J Clin Exp Hematop 2007; 47:79–81.
  • Abe R, Ogawa K, Maruyama Y, et al. Spontaneous regression of diffuse large B-cell lymphoma harbouring Epstein-Barr virus: a case report and review of the literature. J Clin Exp Hematop 2007;47:23–26.
  • Iwatani T, Kawabata H, Miura D, et al. Complete spontaneous regression of primary diffuse large B-cell lymphoma of the breast. J Clin Oncol 2011;29:e113–115.
  • Mizuno T, Ishigaki M, Nakajima K, et al. Spontaneous remission of epstein-barr virus-positive diffuse large B-cell lymphoma of the elderly. Case Rep Oncol 2013;6:269–274.
  • Bernard MP, Bancos S, Sime PJ, et al. Targeting cyclooxygenase-2 in hematological malignancies: rationale and promise. Curr Pharm Des 2008;14:2051–2060.
  • Paydas S, Ergin M, Erdogan S, et al G. Cyclooxygenase-2 expression in non-Hodgkin’s lymphomas. Leuk Lymphoma 2007;48:389–395.
  • Wun T, McKnight H, Tuscano JM. Increased cyclooxygenase-2 (COX-2): a potential role in the pathogenesis of lymphoma. Leuk Res 2004;28:179–190.
  • Holt D, Ma X, Kundu N, et al. Prostaglandin E(2) (PGE (2)) suppresses natural killer cell function primarily through the PGE(2) receptor EP4. Cancer Immunol Immunother 2011;60:1577–1586.
  • Kato I, Koenig KL, Shore RE, et al. Use of anti-inflammatory and non-narcotic analgesic drugs and risk of non-Hodgkin’s lymphoma (NHL) (United States). Cancer Causes Control 2002;13:965–974.
  • Yoshinaga K, Teramura M, Iwabe K, et al. Anti-lymphoma effect of naproxen and indomethacin in a patient with relapsed diffuse large B-cell lymphoma. Am J Hematol 2001;66:220–223.
  • Brown DM, Phipps RP. Characterization and regulation of prostaglandin E2 receptors on normal and malignant murine B lymphocytes. Cell Immunol 1995;161:79–87.
  • Flick ED, Chan KA, Bracci PM, et al. Use of nonsteroidal antiinflammatory drugs and non-Hodgkin lymphoma: a population-based case-control study. Am J Epidemiol 2006;164:497–504.
  • Zhang Y, Coogan PF, Palmer JR, et al. Risk of non-Hodgkin lymphoma and use of non-steroidal anti-inflammatory drugs. Cancer Detect Prev 2006;30:99–101.
  • Fedyk ER, Ripper JM, Brown DM, et al. A molecular analysis of PGE receptor (EP) expression on normal and transformed B lymphocytes: coexpression of EP1, EP2, EP3beta and EP4. Mol Immunol 1996;33: 33–45.
  • Chen ST, Thomas S, Gaffney KJ, et al. Cytotoxic effects of celecoxib on Raji lymphoma cells correlate with aggravated endoplasmic reticulum stress but not with inhibition of cyclooxygenase-2. Leuk Res 2010;34:250–253.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.